BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 11:55:00 AM | Browse: 1268 | Download: 2055
Publication Name World Journal of Methodology
Manuscript ID 13537
Country United States
ISSN 2222-0682 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Toxicology
Manuscript Type Review
Article Title Past, present and future of cyanide antagonism research: From the early remedies to the current therapies
Manuscript Source Invited Manuscript
All Author List Ilona Petrikovics, Marianna Budai, Kristof Kovacs and David E Thompson
Funding Agency and Grant Number
Funding Agency Grant Number
Robert A. Welch Foundation at Sam Houston State University x-0011
Corresponding Author Ilona Petrikovics, PhD, Department of Chemistry, Sam Houston State University, 1806 Avenue J, Huntsville, TX 77341, United States. ixp004@shsu.edu
Key Words Cyanide; Hydrocyanic acid; Antagonist; Antidote; Cobinamide; Sulfanegen; Sulfane sulfur donor
Core Tip This paper reviews milestones in antidotal therapies for cyanide (CN) spanning early history, current antidotal systems, and research towards next generation therapies. Presently used CN therapies include: methemoglobin/nitric oxide generators (e.g., sodium nitrite, amyl nitrite, and dimethyl aminophenol), sulfur donors (e.g., sodium thiosulfate and glutathione), and direct binding agents (e.g., hydroxocobalamin and dicobalt edetate). New antidotes, formulations, and delivery systems are presently being developed for rapid administration at the point of intoxication in mass casualty scenarios. These hold promise for a new generation of improved CN countermeasures.
Publish Date 2015-07-07 20:52
Citation Petrikovics I, Budai M, Kovacs K, Thompson DE. Past, present and future of cyanide antagonism research: From the early remedies to the current therapies. World J Methodol 2015; 5(2): 88-100
URL http://www.wjgnet.com/2222-0682/full/v5/i2/88.htm
DOI http://dx.doi.org/10.5662/wjm.v5.i2.88
Full Article (PDF) WJM-5-88.pdf
Full Article (Word) WJM-5-88.doc